MARK S. GEISSLER, M.D.

MARQUETTE, MI

Research Active
Surgery - Plastic and Reconstructive Surgery NPI registered 21+ years 45 publications 2019 – 2025 NPI: 1740287101
MutationSARS-CoV-2COVID-19PrognosisAntineoplastic Combined Chemotherapy ProtocolsColorectal NeoplasmsBrain NeoplasmsDNAWastewaterNeoplasm MetastasisMicrofluidic Analytical TechniquesRNA, ViralNucleic Acid HybridizationMicrofluidicsLab-On-A-Chip Devices

Practice Location

1414 W FAIR AVENUE
MARQUETTE, MI 49855-2675

Phone: (906) 225-3853

What does MARK GEISSLER research?

Dr. Geissler studies the biological mechanisms behind cancer metastasis and the effectiveness of specific treatments for various cancers, including colorectal cancer and esophagogastric cancer. He also investigates innovative diagnostic techniques for infectious diseases, particularly respiratory viruses and SARS-CoV-2. His research aims to enhance the quality of biological samples used in studies, leading to better therapeutic outcomes and more rapid detection of infections through advanced technologies like microfluidics and machine learning.

Key findings

  • In a study on brain tumor samples, 69% (38 out of 55) were found suitable for research, with lower quality associated with more dead tissue on MRI scans.
  • For BRAF-mutant metastatic colorectal cancer, patients with left-sided tumors had a 58% response rate to anti-EGFR therapy compared to 34% for other treatments.
  • A new sepsis prediction test demonstrated about 90% accuracy within the first 24 hours in intensive care settings using blood samples from 586 patients.
  • In wastewater testing, influenza A was detected in 20.5% of samples, while RSV-A was found in 32.6%, providing insights into community infection trends.
  • Using a new diagnostic device, researchers achieved 100% accuracy in detecting SARS-CoV-2 in 14 patients, identifying levels down to 0.1 viral copies per microliter.

Frequently asked questions

Does Dr. Geissler study cancer treatments?
Yes, he studies various cancer treatments, including those for colorectal cancer and esophagogastric cancer, exploring how different factors affect treatment efficacy.
What diagnostic methods has Dr. Geissler researched?
He has developed innovative diagnostic methods using microfluidics and machine learning for quickly detecting viruses and predicting serious conditions like sepsis.
Is Dr. Geissler's work relevant to infectious diseases?
Absolutely, he investigates respiratory viruses and SARS-CoV-2 detection in wastewater and clinical settings, which is crucial for public health monitoring.
Can Dr. Geissler's research help improve cancer patient outcomes?
Yes, his studies aim to enhance the quality of treatment by identifying effective therapies based on tumor characteristics and improving diagnostic methods.
What public health issues does Dr. Geissler address?
He addresses public health issues related to tracking virus outbreaks and improving diagnostic capabilities to manage infectious diseases more effectively.

Publications in plain English

Microfluidic Integration of Magnetically Functionalized Microwires for Flow Cytometry Protein Quantification.

2025

Materials (Basel, Switzerland)

Clime L, Pavel C, Malic L, Nassif C, Geissler M +9 more

Plain English
The study explored a new method to measure proteins in blood using a small device that combines microfluidics and special magnetic beads. They tested this method on ICAM-1 protein levels in human blood and found it works well, showing promising results. This method could make it easier to quickly and accurately measure proteins in medical settings, which is important for diagnosing and monitoring various health conditions. Who this helps: This helps patients and doctors, especially in urgent healthcare situations.

PubMed

A machine learning and centrifugal microfluidics platform for bedside prediction of sepsis.

2025

Nature communications

Malic L, Zhang PGY, Plant PJ, Clime L, Nassif C +18 more

Plain English
Researchers studied how to quickly and accurately predict the worsening of sepsis, a serious condition caused by infection. They used blood samples from 586 patients and developed a test that can predict deteriorating health within the first 24 hours with about 90% accuracy in intensive care units and 70% in emergency rooms. This matters because timely detection can lead to better treatment outcomes and improve survival rates for patients at risk of sepsis. Who this helps: This helps patients at risk for sepsis and their healthcare providers.

PubMed

Publisher Correction: A machine learning and centrifugal microfluidics platform for bedside prediction of sepsis.

2025

Nature communications

Malic L, Zhang PGY, Plant PJ, Clime L, Nassif C +18 more

PubMed

Methodic aspects of influenza and respiratory syncytial virus detection in raw wastewater and presence in treatment plants in southeastern Germany.

2025

Scientific reports

Geissler M, Berndt H, Herberger E, Wilms K, Dumke R

Plain English
This study examined how well different methods detect influenza and respiratory syncytial viruses (RSV) in raw wastewater from treatment plants in southeastern Germany. The researchers tested samples from eight treatment plants over a year and found that 20.5% of samples showed the presence of influenza A (including 2.2% of the H1N1 strain) and 32.6% showed RSV-A. These findings are important because they help improve our understanding of how to monitor these viruses in wastewater, which can reflect trends in community infection rates. Who this helps: This helps public health officials and researchers track respiratory virus trends to better manage outbreaks.

PubMed

Electrochemical coupling at the plasma membrane by mouse voltage-sensitive phosphatase requires association with basigin.

2025

Cell reports

Shaikh IG, Kostritskii AY, Renigunta A, Jeschke J, Halaszovich CR +8 more

Plain English
This study looked at the role of a specific enzyme called mouse voltage-sensitive phosphatase (mVSP) in the plasma membrane of cells, focusing on how it interacts with a protein named basigin. The researchers found that when basigin is present, mVSP moves to the cell surface, allowing it to function better and respond to changes in cell voltage. They discovered that mVSP can effectively remove certain phosphoinositides when activated by voltage changes, with a range that is more negative than similar enzymes found in non-mammalian species. Who this helps: This helps researchers and doctors understand sperm function and could lead to better reproductive health treatments.

PubMed

Impact of preoperative clinical patient parameters on surgically obtained brain metastasis samples for translational research.

2025

Molecular and cellular probes

Rombach A, Geissler M, Xiao L, Qasem LE, Stange L +15 more

Plain English
This study looked at factors that affect the quality of brain tumor samples taken from patients during surgery, which are important for cancer research. The researchers collected 55 samples and found that 69% (38 samples) were suitable for further research. They discovered that samples were less likely to be useful when there was more dead tissue seen on MRI scans or if patients had previously received specific cancer treatments, which affected the sample quality. Who this helps: This helps researchers and doctors by improving the quality of samples used in brain cancer research, ultimately leading to better treatment approaches.

PubMed

Food and Environmental Virology: Use of Passive Sampling to Characterize the Presence of SARS-CoV-2 and Other Viruses in Wastewater.

2024

Food and environmental virology

Geissler M, Mayer R, Helm B, Dumke R

Plain English
This study looked at how well different materials can catch and measure the presence of SARS-CoV-2 and other viruses in wastewater, which helps track virus spread in communities. Researchers found that using cheesecloths was the most effective method, with a 50% detection rate for SARS-CoV-2, while composite samples had a higher detection rate of 98%. Importantly, the presence of SARS-CoV-2 in wastewater did not match up with reported COVID-19 cases in the community, suggesting that monitoring wastewater can provide different information than traditional case reporting. Who this helps: This research benefits public health officials and communities tracking virus spread.

PubMed

Centrifugal microfluidic system for colorimetric sample-to-answer detection of viral pathogens.

2024

Lab on a chip

Geissler M, Brassard D, Adam N, Nasheri N, Pilar AVC +9 more

Plain English
This research studied a new system that quickly detects harmful viruses in food, such as norovirus and hepatitis A. The system can accurately identify these viruses in samples with as few as 350 copies of the virus in a microfluidic chip during a streamlined 24-step process. This is important because it speeds up how quickly we can respond to food safety issues, which can help prevent outbreaks from spreading. Who this helps: This helps health officials and food safety inspectors detect viruses more quickly, protecting public health.

PubMed

Enterococci,Gene-Carrying Enterococci, and Vancomycin Concentrations in the Influent of a Wastewater Treatment Plant in Southeast Germany.

2024

Microorganisms

Geissler M, Schröttner P, Oertel R, Dumke R

Plain English
Researchers studied wastewater from a treatment plant in Southeast Germany to check for vancomycin-resistant enterococci, which can be dangerous to health. They found that the average concentration of these bacteria was about 29,736 per milliliter and that only about 2% of them were resistant to vancomycin. Additionally, they detected vancomycin in nearly all samples, with an average concentration of 123.1 ng/L, but there was no link between vancomycin levels and the number of resistant strains. Who this helps: This information is valuable for public health officials and wastewater treatment facilities working to manage antibiotic resistance.

PubMed

Nepeta cataria L. (catnip) can serve as a chassis for the engineering of secondary metabolic pathways.

2024

Biotechnology letters

Geissler M, Neubauer C, Sheludko YV, Brückner A, Warzecha H

Plain English
This study looked at how catnip (Nepeta cataria) can be used to create compounds similar to cannabinoids. Researchers found that traditional testing in catnip is less efficient compared to another plant, Nicotiana benthamiana, showing much lower activity levels—37 units in one type of catnip compared to 676 in Nicotiana. However, catnip can still produce certain compounds, which is important for developing new drugs or therapies. Who this helps: This benefits researchers and developers working on cannabinoid-related medications.

PubMed

Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI.

2024

ESMO open

Alig AHS, Modest DP, Stintzing S, Heinrich K, Geissler M +11 more

Plain English
This study looked at how the side of the primary tumor (either left or right) and the patient's sex affect the effectiveness of a specific cancer treatment in patients with BRAF-mutated metastatic colorectal cancer (mCRC). Researchers analyzed data from 102 patients and found that those with left-sided tumors treated with anti-EGFR antibody had better results, showing a 58% response rate compared to 34% for those receiving other treatments. In contrast, patients with right-sided tumors did not benefit from anti-EGFR therapy, exhibiting poorer outcomes. Who this helps: This research helps patients with colorectal cancer and their doctors by identifying which treatment strategies may be more effective based on tumor location.

PubMed

Sample-to-answer centrifugal microfluidic droplet PCR platform for quantitation of viral load.

2024

Lab on a chip

Malic L, Clime L, Moon BU, Nassif C, Da Fonte D +6 more

Plain English
This study examined a new diagnostic tool that quickly tests for viruses, specifically SARS-CoV-2, using a compact device that processes samples from start to finish. The researchers were able to detect extremely low levels of the virus—down to just 0.1 viral copy per microliter—and correctly identify positive and negative samples from 14 patients with 100% accuracy, outperforming traditional testing methods. This development is important because it improves the speed and reliability of viral testing, which can help control outbreaks and provide better patient care. Who this helps: This helps patients and healthcare providers by delivering fast and accurate virus testing.

PubMed

Microfluidic methods for the diagnosis of acute respiratory tract infections.

2024

The Analyst

Liu KZ, Tian G, Ko AC, Geissler M, Malic L +3 more

Plain English
This study looks at new ways to diagnose acute respiratory tract infections (ARTIs) using microfluidic technology, which allows for quicker and more sensitive testing. It highlights that these methods can significantly improve diagnostic performance, for instance, by reducing the time needed for results and the amount of materials used. This is important because ARTIs like pneumonia and influenza impact public health globally, costing economies considerable resources. Who this helps: Patients and healthcare providers benefit from faster and more accurate diagnostic tools.

PubMed

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.

2023

Annals of oncology : official journal of the European Society for Medical Oncology

Seufferlein T, Uhl W, Kornmann M, Algül H, Friess H +30 more

Plain English
This study looked at two ways of giving chemotherapy to patients with early-stage pancreatic cancer that can be surgically removed: one group received treatment before and after surgery (two cycles before and four after) while the other group received treatment only after surgery (six cycles). The results showed that the group getting chemotherapy before surgery had a disease-free survival rate of 33.3% at 18 months, compared to 41.4% for the surgery-first group, but overall survival was better for the pre-surgery group at 25.5 months compared to 16.7 months for those treated only after surgery. Understanding these treatment options is important because it can help improve outcomes for pancreatic cancer patients. Who this helps: Patients with resectable pancreatic cancer.

PubMed

Regional and temporal differences in the relation between SARS-CoV-2 biomarkers in wastewater and estimated infection prevalence - Insights from long-term surveillance.

2023

The Science of the total environment

Helm B, Geissler M, Mayer R, Schubert S, Oertel R +5 more

Plain English
This study looked at how the levels of SARS-CoV-2 (the virus that causes COVID-19) in wastewater can help estimate how many people are infected in Saxony, Germany. Researchers analyzed wastewater from six treatment plants from February to December 2021, finding that the wastewater virus levels were particularly variable depending on the location and timing of the waves of infection. They discovered that during the third wave, virus concentrations were on average 45% higher compared to the fourth wave, and that the accuracy of their estimates improved significantly when they took into account the time lag between infections and the wastewater sampling. Who this helps: This helps public health officials and researchers track COVID-19 spread more effectively.

PubMed

Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatment.

2023

Journal of cancer research and clinical oncology

Forster MT, Hug M, Geissler M, Voss M, Weber K +4 more

Plain English
This study looked at patients with a type of brain tumor called grade 4 diffuse gliomas to see if those who changed where they got treatment had different outcomes compared to those who stayed at one hospital. Researchers analyzed data from 616 patients and found that those who switched treatment sites were younger, had certain genetic mutations, underwent more aggressive treatments, and generally lived longer. However, when matched with similar patients from the original treatment center, there was no difference in survival rates. This shows that while patients who change treatment sites might have better characteristics, simply moving for treatment doesn’t improve chances of survival. Who this helps: This research helps patients with diffuse gliomas and their doctors understand the impacts of treatment location on outcomes.

PubMed

The Brain Pre-Metastatic Niche: Biological and Technical Advancements.

2023

International journal of molecular sciences

Geissler M, Jia W, Kiraz EN, Kulacz I, Liu X +8 more

Plain English
This research explores how cancer spreads to the brain, focusing on the very early stages before tumor cells arrive. It found that tumors can change the environment in the brain, making it more favorable for cancer cells to settle and grow, a concept called the "pre-metastatic niche." Understanding these early changes is crucial for developing better treatments, as brain metastasis is difficult to treat and often fatal. Who this helps: This benefits patients with cancer, particularly those at risk of brain metastasis.

PubMed

Evaluating the sensitivity of droplet digital PCR for the quantification of SARS-CoV-2 in wastewater.

2023

Frontiers in public health

de la Cruz Barron M, Kneis D, Geissler M, Dumke R, Dalpke A +1 more

Plain English
This study examined two methods for detecting the SARS-CoV-2 virus in wastewater: a common technique called RTqPCR and a newer technique called RTddPCR. Researchers found both methods to be effective, with no significant advantage for RTddPCR in detecting more samples than RTqPCR, which means both are reliable for monitoring the virus. This is important because monitoring wastewater can help public health officials spot early signs of COVID-19 outbreaks and respond quickly, potentially preventing the spread of the virus. Who this helps: This research benefits public health officials and communities by providing effective tools for virus monitoring.

PubMed

S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma-final results of the randomized AIO MATEO phase II trial.

2023

ESMO open

Stocker G, Lorenzen S, Ettrich T, Herz AL, Longo F +14 more

Plain English
In this study, researchers looked at whether a treatment called S-1 could be a safe and effective follow-up option for patients with advanced esophagogastric cancer after initial chemotherapy, comparing it to continued chemotherapy. They found that patients taking S-1 had a median survival of 13.4 months, compared to 11.4 months for those who continued with chemotherapy, and S-1 also resulted in fewer side effects (about 85% experienced issues versus 94% with the ongoing treatment). This finding suggests that doctors might consider S-1 maintenance therapy as a better option, potentially improving patients' quality of life while still maintaining similar survival rates. Who this helps: This helps patients with advanced esophagogastric cancer.

PubMed

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.

2022

Annals of oncology : official journal of the European Society for Medical Oncology

Novello S, Torri V, Grohe C, Kurz S, Serke M +31 more

Plain English
The study compared two types of chemotherapy for patients with early-stage non-small-cell lung cancer (NSCLC) after surgery. It involved 773 patients, with around 390 receiving standard chemotherapy and 384 receiving a personalized chemotherapy approach. After nearly 46 months, 65.4% of patients treated with standard chemotherapy were alive, while 72.9% of those given personalized treatment were alive, indicating a potential benefit for the tailored approach, though the findings weren't statistically significant. Who this helps: This study benefits lung cancer patients who have undergone surgery and are exploring treatment options.

PubMed

Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].

2022

Annals of oncology : official journal of the European Society for Medical Oncology

Novello S, Torri V, Grohe C, Kurz S, Serke M +31 more

PubMed

Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy.

2022

Cancers

Alig AHS, Heinemann V, Geissler M, Fischer von Weikersthal L, Decker T +14 more

Plain English
This study looked at how the exact location of the primary tumor in patients with metastatic colorectal cancer (mCRC) affects prognosis and the effectiveness of anti-EGFR treatments. The results showed that tumors in the caecum are linked to worse survival rates, while those in the sigmoid and rectal regions are associated with significant benefits from treatment; specifically, patients with rectal tumors had a 42% lower risk of dying compared to those with caecal tumors. Understanding this can help doctors make better treatment decisions for patients. Who this helps: This helps patients with metastatic colorectal cancer and their doctors.

PubMed

Use of Polymer Micropillar Arrays as Templates for Solid-Phase Immunoassays.

2022

ACS applied polymer materials

Geissler M, Ponton A, Nassif C, Malic L, Turcotte K +3 more

Plain English
This study looks at using small, pillar-like structures to improve tests that detect specific proteins, like those involved in immune responses or diseases. The researchers found that using these micropillar arrays, which provide a larger surface area for antibody attachment, significantly boosts the test's effectiveness, allowing them to detect protein markers at very low concentrations, down to around 1 picogram per milliliter. This advancement could enhance the accuracy of important medical tests, helping in early disease detection and monitoring. Who this helps: Patients needing accurate diagnostic tests for conditions like infections or immune disorders.

PubMed

Automated sample-to-answer centrifugal microfluidic system for rapid molecular diagnostics of SARS-CoV-2.

2022

Lab on a chip

Malic L, Brassard D, Da Fonte D, Nassif C, Mounier M +5 more

Plain English
This study looked at a new automated testing system for detecting the virus that causes COVID-19, specifically using a method called RT-LAMP, which can provide results much faster than traditional tests. The researchers developed a fully automated process that can accurately detect SARS-CoV-2 in as little as 60 minutes and found it to be highly sensitive, detecting as few as 0.5 copies of the virus per microliter, matching the accuracy of standard PCR tests. This is important because it could significantly improve how quickly and easily we can test for COVID-19, especially during surges in cases. Who this helps: This helps patients and public health officials by providing faster and more reliable testing options.

PubMed

Quantitative Feedback Referencing for Improved Kinetic Fitting of Scanning Electrochemical Microscopy Measurements.

2022

Analytical chemistry

Skaanvik SA, Stephens LI, Gateman SM, Geissler M, Mauzeroll J

Plain English
This study focused on improving a technique called scanning electrochemical microscopy (SECM), which is used to analyze tiny electrochemical processes. Researchers found that by using a new method called quantitative feedback referencing (QFR), they could accurately measure the distance between the microscopic probe and the surface being studied, resulting in better and more objective data collection. This is important because it enhances the accuracy of SECM measurements, making it easier to understand chemical reactions at a small scale. Who this helps: This helps researchers and scientists who study electrochemistry and related fields.

PubMed

Simultaneous Detection of SARS-CoV-2 and Influenza Virus in Wastewater of Two Cities in Southeastern Germany, January to May 2022.

2022

International journal of environmental research and public health

Dumke R, Geissler M, Skupin A, Helm B, Mayer R +4 more

Plain English
Researchers studied wastewater from two cities in Germany to detect the presence of SARS-CoV-2 and influenza viruses between January and May 2022. They found SARS-CoV-2 RNA in all 273 samples, indicating widespread virus circulation, and influenza A was found in 5.2% and 41.6% of samples from the two treatment plants, while influenza B was detected in 36.0% and 57.7% of samples. This matters because tracking these viruses in wastewater can provide crucial information on their spread in the population, even when the number of reported infections is low. Who this helps: This research helps public health officials and policymakers in monitoring and responding to viral outbreaks.

PubMed

Real-time monitoring of bead-based DNA hybridization in a microfluidic system: study of amplicon hybridization behavior on solid supports.

2021

The Analyst

Boissinot K, Peytavi R, Chapdelaine S, Geissler M, Boissinot M +7 more

Plain English
This study focused on a new method for monitoring how DNA strands attach and detach from a surface using tiny beads. Researchers found that longer overhanging ends of DNA strands cause them to release from their binding spots at a rate similar to how quickly they initially attach. This is important because it can improve how we test for and identify specific genetic materials rapidly, like detecting certain bacteria in a matter of minutes. Who this helps: This helps patients requiring rapid diagnostic tests, particularly for infections.

PubMed

Relationships Between Köhne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer.

2021

Clinical colorectal cancer

Sartore-Bianchi A, García-Alfonso P, Geissler M, Köhne CH, Peeters M +6 more

Plain English
This study looked at how early tumor shrinkage and treatment response in patients with metastatic colorectal cancer are related to their initial cancer characteristics. Researchers found that patients in the low-risk group had a 63.8% chance of experiencing significant tumor shrinkage, while those with BRAF mutations had only a 21.7% chance. Achieving early tumor shrinkage or a strong response to treatment was linked to longer survival for patients. Who this helps: This helps patients with metastatic colorectal cancer and their doctors understand which patients may respond better to treatment.

PubMed

Multifunctional magnetic nanoparticle cloud assemblies forcapture of bacteria and isolation of microbial DNA.

2021

The Analyst

Poncelet L, Malic L, Clime L, Geissler M, Morton KJ +4 more

Plain English
This study looks at a new method using tiny magnetic particles, called M-clouds, to capture harmful bacteria from water and extract their DNA. Researchers found that this method could detect E. coli O157:H7 at very low levels—just 10 bacteria per milliliter—and produced ten times more DNA than previous methods. This is important because it allows for quicker and more efficient testing for dangerous bacteria in water sources. Who this helps: This research benefits water safety inspectors and environmental health professionals.

PubMed

Controlled and Local Delivery of Antibiotics by 3D Core/Shell Printed Hydrogel Scaffolds to Treat Soft Tissue Infections.

2021

Pharmaceutics

Akkineni AR, Spangenberg J, Geissler M, Reichelt S, Buechner H +2 more

Plain English
Researchers studied a new way to deliver antibiotics to treat soft tissue infections, which can happen after injuries like fractures or burns. They created a special 3D-printed scaffold that releases antibiotics slowly over seven days, maintaining effective levels in the affected area without sudden spikes in dosage. This method is important because it can help ensure that infections are treated more effectively and reduces the risk of complications in patients. Who this helps: This benefits patients with soft tissue infections following injuries.

PubMed

Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma.

2020

European journal of cancer (Oxford, England : 1990)

Hartmann JT, Kopp HG, Gruenwald V, Piperno-Neumann S, Kunitz A +14 more

Plain English
This study compared the effectiveness and safety of two cancer treatments, trofosfamide and doxorubicin, in older patients with a type of cancer called metastatic soft-tissue sarcoma. Out of 120 patients over 60 years old, 35.9% of those taking doxorubicin and 27.6% taking trofosfamide were free from cancer progression after 6 months. Trofosfamide had fewer severe side effects, making it a potentially safer option for elderly patients. Who this helps: This helps elderly cancer patients by providing a safer treatment alternative.

PubMed

Polymer Micropillar Arrays for Colorimetric DNA Detection.

2020

Analytical chemistry

Geissler M, Malic L, Morton KJ, Clime L, Daoud J +4 more

Plain English
This study looked at using tiny pillar structures made from plastic to detect DNA, specifically DNA from a harmful bacteria called E. coli O157:H7. Researchers found that the way these micropillars were designed could affect how well the DNA signal was detected, with the best results happening between 20 and 60 minutes of testing. This discovery is important because it helps improve the accuracy and efficiency of DNA detection, which could lead to quicker diagnosis of bacterial infections. Who this helps: This helps patients and healthcare providers by improving diagnostic tests for bacterial infections.

PubMed

Detection of renal biomarkers in chronic kidney disease using microfluidics: progress, challenges and opportunities.

2020

Biomedical microdevices

Liu KZ, Tian G, Ko AC, Geissler M, Brassard D +1 more

Plain English
This study looked at new methods for detecting kidney damage in people with chronic kidney disease (CKD) using a technology called microfluidics. This approach could significantly shorten the time and reduce the costs of testing for CKD, which is currently a slow and expensive process. The goal is to find new, sensitive markers that can catch CKD early, improving patient care and outcomes. Who this helps: This benefits patients, especially those in underserved areas who need quicker and more affordable testing.

PubMed

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109).

2020

Journal of cancer research and clinical oncology

Kurreck A, Geissler M, Martens UM, Riera-Knorrenschild J, Greeve J +15 more

Plain English
This study looked at how patients with metastatic colorectal cancer (mCRC) respond to a specific combination of treatments based on their BRAF gene status and where their tumor started in the body. Researchers found that patients with the normal BRAF gene (BRAF-WT) experienced a much greater decrease in tumor size (57.6% reduction) than those with the mutant BRAF gene (40.8% reduction). Additionally, BRAF-WT patients lived longer without their disease worsening (6.5 months) and had better overall survival (33.6 months) compared to BRAF mutant patients, who had only 2.6 months and 5.4 months, respectively. Who this helps: This helps patients with metastatic colorectal cancer by highlighting the importance of BRAF testing for more personalized treatment options.

PubMed

Acute transverse myelitis after COVID-19 pneumonia.

2020

Journal of neurology

Munz M, Wessendorf S, Koretsis G, Tewald F, Baegi R +3 more

PubMed

[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations].

2020

Zeitschrift fur Gastroenterologie

Attenberger U, Rödel C, Ghadimi M, Piso P, Arnold D +11 more

Plain English
This study looked at how important Magnetic Resonance Imaging (MRI) is for planning treatment in patients with locally advanced rectal cancer. The researchers found that MRI is essential for deciding the best treatment approach and for grouping patients based on their specific needs. This is important because it helps ensure patients receive the most appropriate care, potentially improving their outcomes. Who this helps: Patients with locally advanced rectal cancer.

PubMed

Buoyancy-driven step emulsification on pneumatic centrifugal microfluidic platforms.

2020

Lab on a chip

Clime L, Malic L, Daoud J, Lukic L, Geissler M +1 more

Plain English
This research developed a new way to create small droplets using a special device that spins fluids and uses air pressure to move them. The study found that by balancing the effects of buoyancy and the speed of the fluid flow, they could better control the droplet size. For instance, they showed a reliable method for making droplets of specific sizes, which can improve various applications in science and medicine. Who this helps: This helps researchers and engineers working on drug delivery and other fluid-based technologies.

PubMed

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics.

2020

Journal of visualized experiments : JoVE

Malic L, Elmanzalawy A, Daoud J, Geissler M, Boutin A +5 more

Plain English
This research explored a new testing method to analyze white blood cells (WBCs) by examining specific epigenetic markers, which help to classify the cells and understand disease risks. The study developed a tool using small droplets to measure DNA changes in these cells, making it possible to analyze multiple markers at once without needing separate tests. By accurately identifying different types of WBCs, this method can improve disease diagnosis and treatment outcomes. Who this helps: This benefits patients with blood disorders and their doctors.

PubMed

Centrifugal microfluidic lab-on-a-chip system with automated sample lysis, DNA amplification and microarray hybridization for identification of enterohemorrhagicculture isolates.

2020

The Analyst

Geissler M, Brassard D, Clime L, Pilar AVC, Malic L +6 more

Plain English
This study created a compact device that quickly identifies harmful strains of E. coli in food samples. The process takes less than 2 hours and involves just two manual steps, making it both fast and easy to use. The system can detect seven different types of dangerous E. coli with similar accuracy to more complicated lab equipment. Who this helps: This benefits food safety regulators and health officials who monitor and respond to foodborne illness outbreaks.

PubMed

The mRNA Binding Proteome of Proliferating and Differentiated Muscle Cells.

2020

Genomics, proteomics & bioinformatics

Hiller M, Geissler M, Janssen G, van Veelen P, Aartsma-Rus A +1 more

Plain English
This study looked at how muscle cells change and grow by analyzing how proteins that bind to RNA (messenger molecules) are affected in healthy and diseased muscle conditions. Researchers found that over 7,000 genes changed during muscle formation and identified 769 RNA binding proteins, of which many were specific to muscle. Importantly, they discovered 32 key proteins that could help distinguish between healthy muscle and muscle affected by disease, which could lead to better diagnostic tools. Who this helps: Patients with muscle diseases and their doctors.

PubMed

Surfactin and fengycin contribute to the protection of a Bacillus subtilis strain against grape downy mildew by both direct effect and defence stimulation.

2019

Molecular plant pathology

Li Y, Héloir MC, Zhang X, Geissler M, Trouvelot S +6 more

Plain English
Researchers studied a specific strain of bacteria, Bacillus subtilis GLB191, to see how it protects grapevines from a disease called downy mildew. They found that a substance produced by this bacteria not only directly fights the disease but also boosts the plant's own defenses. Important compounds named surfactin and fengycin were identified as key players in this protective action. Who this helps: This benefits grape farmers and vineyard owners looking for environmentally friendly ways to combat grape downy mildew.

PubMed

Evaluation of surfactin synthesis in a genome reduced Bacillus subtilis strain.

2019

AMB Express

Geissler M, Kühle I, Morabbi Heravi K, Altenbuchner J, Henkel M +1 more

Plain English
This study looked at a modified strain of the bacterium Bacillus subtilis to see if it could produce a substance called surfactin, used in various applications like cleaning products and medicine. Researchers tested this modified strain, named IIG-Bs20-5-1, at different temperatures and found it grew better than a standard strain but did not produce as much surfactin, with the best yields from the standard strain reaching up to 1,147 mg/L under ideal conditions. This matters because improving surfactin production can lead to more effective and versatile products. Who this helps: Patients and industries that rely on surfactin for medical and cleaning applications.

PubMed

Relationship Between Tumor Response and Tumor-Related Symptoms in RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses From 3 Panitumumab Trials.

2019

Clinical colorectal cancer

Taieb J, Geissler M, Rivera F, Karthaus M, Wilson R +5 more

Plain English
This study looked at how quickly tumors shrink and how that relates to symptoms in patients with a specific type of advanced colorectal cancer. Researchers found that patients whose tumors shrank by at least 30% within the first 8 weeks had delayed symptoms compared to those whose tumors did not shrink as much. This matters because it suggests that effective tumor treatment may lead to a better quality of life by reducing the timing of unpleasant symptoms. Who this helps: This helps patients with RAS wild-type metastatic colorectal cancer.

PubMed

FOLFOXIRI Plus Panitumumab As First-Line Treatment ofWild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109).

2019

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Modest DP, Martens UM, Riera-Knorrenschild J, Greeve J, Florschütz A +14 more

Plain English
This study looked at whether adding a drug called panitumumab to a specific chemotherapy regimen (called mFOLFOXIRI) would be more effective for patients with a type of advanced colorectal cancer that has not been treated before. The researchers found that 87.3% of patients responded positively to the combination treatment, which is significantly better than the 60.6% response rate seen with chemotherapy alone. Additionally, the chance of being able to surgically remove tumors after treatment increased from 12.1% to 33.3% with the addition of panitumumab. Who this helps: This benefits patients with wild-type metastatic colorectal cancer who are looking for more effective treatment options.

PubMed

Epigenetic subtyping of white blood cells using a thermoplastic elastomer-based microfluidic emulsification device for multiplexed, methylation-specific digital droplet PCR.

2019

The Analyst

Malic L, Daoud J, Geissler M, Boutin A, Lukic L +3 more

Plain English
This study looked at how to analyze the DNA of white blood cells (WBCs) to better understand different types of these cells based on their DNA methylation patterns. The researchers created a new testing method using a special device that mixes small samples and found that their technique accurately identified various WBC types, matching the results from traditional methods closely. This is significant because it offers a more precise and cost-effective way to conduct blood tests that could help diagnose and monitor diseases more effectively. Who this helps: Patients and doctors who need better tools for blood tests and disease management.

PubMed

Frequent Co-Authors

Teodor Veres Lidija Malic Liviu Clime Christina Nassif Daniel Brassard Ljuboje Lukic Roger Dumke Dillon Da Fonte Jamal Daoud Byeong-Ui Moon

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.